Search results
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 7 hours agoThat's excellent news for Moderna and its shareholders, especially since the company has many, many...
B.Riley lifts Vaxart shares target on BARDA award By Investing.com
Investing.com· 2 days ago(NASDAQ:VXRT) shares to $2.50, up from the previous $2.00, while maintaining a Buy rating on the ...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 3 days agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following insider selling activity. 392,597...session volume of ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
FOX 23 News Albany· 1 day agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance· 6 days agoConsequently, upward revisions in estimates express analysts' positivity towards the company's...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoSome investors might view Moderna (NASDAQ: MRNA) as a shooting star that shined bright for a while then flamed out. In 2022, the biotech company...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoSales are expected to accelerate in a big way in the third quarter, with a projected $1.49 billion,...
State of Tennessee Treasury Department Boosts Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoTreasury Department increased its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 27.5% in the fourth quarter, according to its most recent Form 13F filing with the ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoSince then, the stock has trended lower. The vaccine is based on protein technology, differentiating...